ReviewDrugs2024

GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy.

André J ScheenPubMed ↗Publisher ↗

No numbers read from the abstract.